Harnessing human dendritic cell subsets to design novel vaccines

Annals of the New York Academy of Sciences

Volumn 1174, Issue , 2009, Pages 24-32

  Banchereau, Jacques ^a,b   Klechevsky, Eynav ^a   Schmitt, Nathalie ^a   Morita, Rimpei ^a   Palucka, Karolina ^a,b   Ueno, Hideki ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cell; Immunology; Vaccine

Indexed keywords

DENDRITIC CELL VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CANCER VACCINE; CYTOKINE; INTERLEUKIN 12; LEUKOCYTE ANTIGEN;

CELLULAR IMMUNITY; CONFERENCE PAPER; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; SKIN; T LYMPHOCYTE; B LYMPHOCYTE; DERMIS; DRUG DESIGN; EPIDERMIS; HELPER CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFECTION; LANGERHANS CELL; NEOPLASM; REVIEW;

ANTIGENS, CD; B-LYMPHOCYTES; CANCER VACCINES; CYTOKINES; DENDRITIC CELLS; DERMIS; DRUG DESIGN; EPIDERMIS; HUMANS; IMMUNITY; INFECTION; INTERLEUKIN-12; LANGERHANS CELLS; NEOPLASMS; SELF TOLERANCE; SKIN; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 70350474676     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04999.x     Document Type: Conference Paper

References (45)

1. 1. Yamamura, M. et al. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (New York, N.Y.) 254: 277-279. (Pubitemid 21917340)
2. Banchereau, J & R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
3. Steinman, R.M. &J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
4. Itano, A.A. et al. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19: 47-57.
5. Jego, G., V Pascual, A.K. Palucka &J Banchereau. 2005. Dendritic cells control B cell growth and differentiation. Curr. Dir. Autoimmun. 8: 124-139.
6. 6. Qi, H., JG. Egen, A.Y Huang & R.N. Germain. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science (New Tork, N.Y.) 312: 1672-1676. (Pubitemid 43902670)
7. Batista, F.D. & N.E. Harwood. 2009. The who, how and where of antigen presentation to B cells. Nat. Rev. Immunol. 9: 15-27.
8. 8. Bergtold, A., D.D. Desai, A. Gavhane & R. Clynes. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23: 503-514. (Pubitemid 41587890)
9. Steinman, R.M., D. Hawiger & M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
10. 10. Ueno, H. et al. 2007. Dendritic cell subsets in health and disease. Immunol Rev. 219: 118-142. (Pubitemid 47393528)
11. 11. Blanco, P., A.K. Palucka, M. Gill, et al. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science (New Tork, N.Y.) 294: 1540-1543. (Pubitemid 33063928)
12. 12. Siegal, F.P. et al. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science (New Tork, N.Y.) 284: 1835-1837. (Pubitemid 29275623)
13. 13. Cao, W et al. 2006. Plasmacytoid dendritic cellspecific receptor ILT7-Fc epsilonRI gamma inhibits toll-like receptor-induced interferon production. J. Exp. Med. 203: 1399-1405. (Pubitemid 43877601)
14. 14. Kadowaki, N. et al. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869. (Pubitemid 32983021)
15. 15. Maldonado-Lopez, R. et al. 1999. CDSalpha +and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592. (Pubitemid 29187380)
16. 16. Pulendran, B. et al. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96: 1036-1041. (Pubitemid 129660276)
17. 17. Dudziak, D. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science (New Tork, N.Y.) 315: 107-111. (Pubitemid 46196991)
18. Valladeau, J. & S. Saeland. 2005. Cutaneous dendritic cells. Semin. Immunol. 17: 273-283.
19. Van Der Aar, A.M. 2007. Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 178: 1986-1990.
20. Klechevsky, E. et al. 2009. Linderstanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum. Immunol. 70: 281-288.
21. 21. Flacher, V et al. 2006. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177: 7959-7967. (Pubitemid 44846312)
22. Klechevsky, E. et al. 2009. Linderstanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum. Immunol. 70: 281-288.
23. 23. Caux, C et al. 1996. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J. Exp. Med. 184: 695-706. (Pubitemid 26324123)
24. 24. Caux, C et al. 1997. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90: 1458-1470. (Pubitemid 27355417)
25. Klechevsky, E. et al. 2008. Functional specializations of human epidermal Langerhans cells and CD 14+ dermal dendritic cells. Immunity 29: 497-510.
26. Schmitt, N. et al. 2009. Human dendritic cells induce the differentiation of interleukin-21 -producing T follicular helper-like cells through interleukin-12. Immunity 31: 158-169.
27. 27. Zhou, L. et al. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol 8: 967-974. (Pubitemid 47300011)
28. 28. Mestas, J & C.C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology, J. Immunol 172: 2731-2738. (Pubitemid 38263654)
29. Alvarez, D. et al. 2005. Cutaneous antigen priming via gene gun leads to skin-selective Th2 immuneinflammatory responses. J Immunol. 174: 1664-1674.
30. 30. Oh, S., L.P. Perera, D.S. Burke, et al. 2004. IL-15/IL15 Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 101: 15154-15159. (Pubitemid 39391734)
31. Celluzzi, C.M. & L.D. Falo, Jr. 1997. Epidermal dendritic cells induce potent antigen-specific CTLmediated immunity, J. Invest. Dermatol. 108: 716-720.
32. 32. Stoitzner, P. et al. 2006. Langerhans cells crosspresent antigen derived from skin. Proc. Natl Acad. Sci. USA 103: 7783-7788. (Pubitemid 43752858)
33. 33. Zhao, X. et al. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162. (Pubitemid 36152310)
34. Allan, R.S. et al. 2003. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science (New Tork, N.Y.) 301: 1925-1928.
35. 35. Bosnjak, L. et al. 2005. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174: 2220-2227. (Pubitemid 40223968)
36. 36. Kissenpfennig, A. et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slowermigrating Langerhans cells. Immunity 22: 643-654. (Pubitemid 40719199)
37. Caminschi, I., M.H. Lahoud & K. Shortman. 2009. Enhancing immune responses by targeting antigen to DC. Eur. J. Immunol. 39: 931-938.
38. Idoyaga, J et al. 2008. Cutting edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180: 3647-3650.
39. Manicassamy, S. et al. 2009. Toll-like receptor 2dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15: 401-409.
40. 40. Mora, JR. et al. 2003. Selective imprinting of guthoming T cells by Peyer's patch dendritic cells. Nature 424: 88-93. (Pubitemid 36834847)
41. Pulendran, B. & R. Ahmed. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124: 849-863.
42. 42. Letvin, N.L. 2007. Correlates of immune protection and the development of human immunodeficiency virus vaccine. Immunity 27: 366-369. (Pubitemid 47418683)
43. Frey, S.E. et al. 2002. Dose-related effects of smallpox vaccine. N Engl J. Med. 346: 1275-1280.
44. 44. Querec, T et al. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203: 413-424. (Pubitemid 43290850)
45. Gaucher, D. et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205: 3119-3131.